CUE
Cue Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.44
−0.83%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 65.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 86.29x
- Price / sales
- 5.29x
- Price / cash flow
- -3.98x
Enterprise value
- Enterprise value
- $190.8M
- EV / sales
- 5.07x
- EV / EBITDA
- -1.99x
- EV / EBIT
- -1.93x
- Market cap
- $199.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026